Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Consumer wearables become the new gatekeepers of clinical health care

29

May 2026

Consumer wearables become the new gatekeepers of clinical health care

JMIR Publications today released a News and Perspectives expert analysis on consumer wearable platforms' forays into the clinical health care space. Authored by MedTech expert Blythe Karow, MBA, "Meet the New Health Care Gatekeeper: Your Wearable" lays out the implications of wearable tech companies owning the first conversation about a patient's health, as well as the potential impacts on patient trust, policy, and regulation.

Researchers develop open source framework for health AI research

29

May 2026

Researchers develop open source framework for health AI research

A research team led by Columbia University has developed an open-source framework designed to streamline and accelerate artificial intelligence research using health data, addressing longstanding challenges in data standardization, reproducibility, and collaboration across institutions.

Survey reveals critical knowledge gaps in maternal health recommendations

29

May 2026

Survey reveals critical knowledge gaps in maternal health recommendations

Most Americans know that how well a mother takes care of herself before and during pregnancy affects the health of a baby, but many people remain unclear about some specific maternal health recommendations, including when to start avoiding alcohol, according to a new nationally representative survey from the Annenberg Public Policy Center (APPC) of the University of Pennsylvania.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.